Indicators
Indicators
Value
Direction
MACD(12,26,9)
-2.332
Neutral
RSI(14)
58.206
Neutral
STOCH(KDJ)(9,3,3)
32.513
Buy
ATR(14)
2.092
High Vlolatility
CCI(14)
-41.387
Neutral
Williams %R
63.332
Sell
TRIX(12,20)
0.434
Sell
StochRSI(14)
100.000
Buy
Globus Medical Inc
GMED87.000USD
+0.120+0.14%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
11.71BMarket Cap
27.83P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Globus Medical Inc
Currency: USD Updated: 2025-12-19Key Insights
Globus Medical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 94.09.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Globus Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
94.091
Target Price
+5.72%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Globus Medical Inc Highlights
StrengthsRisks
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 146.31% year-on-year.
Undervalued
The company’s latest PE is 27.85, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 117.81M shares, decreasing 5.92% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 999.22K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Globus Medical Inc is 9.32, ranking 8/208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 769.05M, representing a year-over-year increase of 22.91%, while its net profit experienced a year-over-year increase of 129.50%.
Score
Financials
9.79
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.26
Operational Efficiency
10.00
Growth Potential
9.93
Shareholder Returns
7.64
Globus Medical Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Globus Medical Inc is 7.35, ranking 96/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 27.85, which is 1202.60% below the recent high of 362.76 and 28.97% above the recent low of 19.78.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 26/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Globus Medical Inc is 7.47, ranking 133/208 in the Healthcare Equipment & Supplies industry. The average price target for Globus Medical Inc is 92.00, with a high of 114.00 and a low of 76.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
94.091
Target Price
+5.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
112
Total
6
Median
9
Average
Company name
Ratings
Analysts
Globus Medical Inc
GMED
15
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Globus Medical Inc is 7.35, ranking 69/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 92.26 and the support level at 82.07, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
86.258
Buy
MA10
87.211
Sell
MA20
88.289
Sell
MA50
76.447
Buy
MA100
67.475
Buy
MA200
65.898
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Globus Medical Inc is 10.00, ranking 1/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 104.61%, representing a quarter-over-quarter increase of 2.47%. The largest institutional shareholder is The Vanguard, holding a total of 10.58M shares, representing 9.50% of shares outstanding, with 1.46% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Janus Henderson Investors
Sculptor Capital Management, Inc
State Street Investment Management (US)
Burgundy Asset Management Ltd.
JP Morgan Asset Management
William Blair Investment Management, LLC
Madison Avenue Partners LP
Geneva Capital Management LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Globus Medical Inc is 5.45, ranking 78/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.07
VaR
+2.89%
240-Day Maximum Drawdown
+44.40%
240-Day Volatility
+45.96%
Return
Best Daily Return
60 days
+35.94%
120 days
+35.94%
5 years
+35.94%
Worst Daily Return
60 days
-5.10%
120 days
-7.90%
5 years
-22.96%
Sharpe Ratio
60 days
+2.74
120 days
+1.59
5 years
+0.37
Risk Assessment
Maximum Drawdown
240 days
+44.40%
3 years
+44.40%
5 years
+47.91%
Return-to-Drawdown Ratio
240 days
+0.08
3 years
+0.09
5 years
+0.16
Skewness
240 days
+3.57
3 years
+2.93
5 years
+2.16
Volatility
Realised Volatility
240 days
+45.96%
5 years
+35.83%
Standardised True Range
240 days
+2.41%
5 years
+2.07%
Downside Risk-Adjusted Return
120 days
+446.40%
240 days
+446.40%
Maximum Daily Upside Volatility
60 days
+76.34%
Maximum Daily Downside Volatility
60 days
+64.02%
Liquidity
Average Turnover Rate
60 days
+1.04%
120 days
+1.09%
5 years
--
Turnover Deviation
20 days
+14.63%
60 days
+19.78%
120 days
+25.80%
Peer Comparison
Healthcare Equipment & Supplies
Globus Medical Inc
GMED
7.94 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Globus Medical Inc?
The TradingKey Stock Score provides a comprehensive assessment of Globus Medical Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Globus Medical Inc’s performance and outlook.
How do we generate the financial health score of Globus Medical Inc?
To generate the financial health score of Globus Medical Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Globus Medical Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Globus Medical Inc.
How do we generate the company valuation score of Globus Medical Inc?
To generate the company valuation score of Globus Medical Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Globus Medical Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Globus Medical Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Globus Medical Inc.
How do we generate the earnings forecast score of Globus Medical Inc?
To calculate the earnings forecast score of Globus Medical Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Globus Medical Inc’s future.
How do we generate the price momentum score of Globus Medical Inc?
When generating the price momentum score for Globus Medical Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Globus Medical Inc’s prices. A higher score indicates a more stable short-term price trend for Globus Medical Inc.
How do we generate the institutional confidence score of Globus Medical Inc?
To generate the institutional confidence score of Globus Medical Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Globus Medical Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Globus Medical Inc.
How do we generate the risk management score of Globus Medical Inc?
To assess the risk management score of Globus Medical Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Globus Medical Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Globus Medical Inc.
